Skip to main content

Table 3 Relationships between expression of VEGFR-2,DGFR-β, and c-MET and prognosis in HCC patients who took sorafenib

From: Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma

  N PFS OS
  Months χ 2 P months χ 2 P
PDGFR-β 65       
High 13 4.23    5.87   
Low 52 5.60 1.345 0.246 8.97 3.996 0.046
VEGFR-2 65       
High 58 4.97    7.40   
Low 7 7.93 0.391 0.532 11.37 0.514 0.473
c-MET 65       
High 55 5.60    8.97   
Low 10 1.43 6.558 0.010 6.47 0.930 0.335
  1. VEGFR-2, vascular endothelial growth factor receptor-2; PDGFR-β, platelet-derived growth factor receptor-β; C-MET, hepatocyte growth factor receptor; PFS, progression-free survival; OS, overall survival.